Surgical oncology

NexCore Group and Arizona Oncology Celebrate the Opening of New Cancer Center in Prescott, Arizona

Retrieved on: 
Wednesday, November 8, 2023
Science, Urology, McKesson Corporation, Surgical oncology, Breast cancer, CT, Cancer, LINAC, Patient, Google Images, HDR, Oncology, Hospital, Nursing, Medical imaging

DENVER, Nov. 8, 2023 /PRNewswire-PRWeb/ -- NexCore Group, a national healthcare, life sciences, and senior living real estate developer, celebrated the grand opening of a new cancer center October 27 serving the residents in Prescott, Arizona. Arizona Oncology, one of the largest medical groups in Arizona devoted exclusively to cancer care, and NexCore collaborated on the 23,000-square-foot facility which opened to the public in October 2023. The Arizona Oncology Cancer Center offers patients in the region convenient access to the latest cancer treatment services and technologies.

Key Points: 
  • The Arizona Oncology Cancer Center offers patients in the region convenient access to the latest cancer treatment services and technologies.
  • The Arizona Oncology Cancer Center offers patients in the region convenient access to the latest cancer treatment services and technologies.
  • "The Prescott community now has access to exceptional cancer care at the newly opened Arizona Oncology center, a project realized through the collaboration of NexCore Group with McKesson and US Oncology.
  • "The Prescott community now has access to exceptional cancer care at the newly opened Arizona Oncology center, a project realized through the collaboration of NexCore Group with McKesson and US Oncology", commented NexCore President Jarrod Daddis.

Clarix Imaging Enters into Know-How Agreement with Mayo Clinic in Surgical Oncology and Radiology

Retrieved on: 
Thursday, October 26, 2023
Oncology, Health, Health Technology, Other Health, General Health, Research, Science, 3D, Education, Doctor of Philosophy, Surgical oncology, Mayo Clinic, Medical imaging

Clarix Imaging® , a pioneering force in surgical oncology, proudly announces a collaboration with Mayo Clinic to catalyze new surgical advancements using Clarix Imaging’s proprietary and patented volumetric specimen imaging hardware and software technology.

Key Points: 
  • Clarix Imaging® , a pioneering force in surgical oncology, proudly announces a collaboration with Mayo Clinic to catalyze new surgical advancements using Clarix Imaging’s proprietary and patented volumetric specimen imaging hardware and software technology.
  • Clarix Imaging’s technology generates true 3D images of surgical specimens intraoperatively.
  • The aim of the know-how agreement with Mayo Clinic is to develop novel clinical solutions to enhance patient care during breast cancer surgery.
  • Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

Mediacom and Employees Raise Over $30,000 for Breast Cancer Awareness & Research

Retrieved on: 
Tuesday, October 24, 2023
Carriers and Services, Mobile, Wireless, Networks, Professional Services, Internet, Philanthropy, Oncology, Technology, Fund Raising, Audio, Video, Health, Environmental, Social and Governance (ESG), Telecommunications, American Cancer Society, Mediacom, Garnet Health, Research, Administration, Friends, Paramjeet Singh, Surgical oncology, Survival rate, Breast cancer, Woman, Birth control

Mediacom Communications and its employees proudly participated in the annual Making Strides of Hudson Valley walk day raising over $30,000 for the American Cancer Society.

Key Points: 
  • Mediacom Communications and its employees proudly participated in the annual Making Strides of Hudson Valley walk day raising over $30,000 for the American Cancer Society.
  • A Mediacom specific event was hosted at the company’s Mediacom Park headquarters where attendees walked along the property’s nature trail.
  • “Mediacom is proud to continue supporting the fight against Breast Cancer by participating in Making Strides for the ninth consecutive year,” said Catherine Commisso, Mediacom’s Group VP of Administration.
  • “We hope that women can achieve a better survival rate and someday have the possibility of eliminating breast cancer as the second leading cancer death for women.”

Join Us at ESSO42 - Confidently navigating towards the target with GPSDetect™ Trust and Embrace Surgical Marker Navigation

Retrieved on: 
Monday, October 23, 2023
Physician, Congress, Conference, ESSO, Surgical oncology, Portsmouth Hospitals University NHS Trust, IRCCS, Villa, Hospital Clinic Manuel Quintela, Patient, Sarcoma, Nursing

Sirius Medical has steadily been raising the bar for the surgery of non-palpable breast tumors by moving from first-generation localization techniques to Surgical Marker Navigation.

Key Points: 
  • Sirius Medical has steadily been raising the bar for the surgery of non-palpable breast tumors by moving from first-generation localization techniques to Surgical Marker Navigation.
  • The Pintuition® navigation system with GPSDetect™ software provides unmatched distance and directional guidance to locate tumors easily and accurately.
  • This year at ESSO42 we demonstrate how physicians across the globe are trusting and embracing surgical marker navigation.
  • "We have seen first-hand how trusting and embracing the switch from localization to surgical marker navigation has positively affected patients, physicians, and health systems," says Bram Schermers, CEO of Sirius Medical.

Join Us at ESSO42 - Confidently navigating towards the target with GPSDetect™ Trust and Embrace Surgical Marker Navigation

Retrieved on: 
Monday, October 23, 2023
Physician, Congress, Conference, ESSO, Surgical oncology, Portsmouth Hospitals University NHS Trust, IRCCS, Villa, Hospital Clinic Manuel Quintela, Patient, Sarcoma, Nursing

Sirius Medical has steadily been raising the bar for the surgery of non-palpable breast tumors by moving from first-generation localization techniques to Surgical Marker Navigation.

Key Points: 
  • Sirius Medical has steadily been raising the bar for the surgery of non-palpable breast tumors by moving from first-generation localization techniques to Surgical Marker Navigation.
  • The Pintuition® navigation system with GPSDetect™ software provides unmatched distance and directional guidance to locate tumors easily and accurately.
  • This year at ESSO42 we demonstrate how physicians across the globe are trusting and embracing surgical marker navigation.
  • "We have seen first-hand how trusting and embracing the switch from localization to surgical marker navigation has positively affected patients, physicians, and health systems," says Bram Schermers, CEO of Sirius Medical.

Tampa General Hospital Cancer Institute Recognized on Becker's List of '100 Hospital and Health Systems with Great Oncology Programs' for 2023

Retrieved on: 
Thursday, October 19, 2023
Radiation, Genetic counseling, Central Florida, Commission, American College, TGH, Psychology, Hope, Cancer Institute, Pathology, Tampa General Hospital, Accreditation, COC, Research, Health, Becker's Hospital Review, Quality of life, Rehabilitation, Radiology, Surgeon, Hospital, Surgical oncology, ACS, Becker's, Palliative care, Social work, Patient, Becker, Nursing, Tampa Bay, Cancer

TAMPA, Fla., Oct. 19, 2023 /PRNewswire/ -- The Tampa General Hospital (TGH) Cancer Institute has been named to Becker's Hospital Review's list of "100 Hospitals and Health Systems with Great Oncology Programs" for 2023.

Key Points: 
  • TAMPA, Fla., Oct. 19, 2023 /PRNewswire/ -- The Tampa General Hospital (TGH) Cancer Institute has been named to Becker's Hospital Review's list of "100 Hospitals and Health Systems with Great Oncology Programs" for 2023.
  • "We are immensely proud to be the only health system in Tampa Bay recognized by Becker's for delivering excellence in cancer care," said John Couris, president and CEO of Tampa General.
  • Part of the region's leading academic health system, the TGH Cancer Institute is a world-class cancer center providing comprehensive, innovative care.
  • Inclusion on this list is the latest among several recent achievements for the TGH Cancer Institute, including:

Hoag Welcomes Dr. Ronald Wolf as Medical Director of Hepatobiliary and Pancreatic Surgery

Retrieved on: 
Tuesday, October 17, 2023
Colon, University of California, Davis, American College, Agility, Cancer, UC, Medical director, Oregon Health & Science University, Pancreas, Memorial Sloan Kettering Cancer Center, Surgical oncology, University of California, Irvine School of Medicine, Culture, General surgery, Society, Patient, Legacy Good Samaritan Medical Center, Medical imaging, Nursing, Dentistry, Liver, Medicine

NEWPORT BEACH, Calif. and IRVINE, Calif., Oct. 17, 2023 /PRNewswire/ -- Hoag is proud to announce the recruitment of Ronald Wolf, M.D., F.A.C.S., as medical director of hepatobiliary and pancreas surgery at Hoag Family Cancer Institute.

Key Points: 
  • NEWPORT BEACH, Calif. and IRVINE, Calif., Oct. 17, 2023 /PRNewswire/ -- Hoag is proud to announce the recruitment of Ronald Wolf, M.D., F.A.C.S., as medical director of hepatobiliary and pancreas surgery at Hoag Family Cancer Institute.
  • Dr. Wolf comes to Hoag from concurrent posts at UC Irvine School of Medicine, where he served as professor of clinical surgery in the hepatobiliary and pancreas surgery/islet cell transplantation division.
  • Prior to that, he served as Medical Director of Hepatic and Pancreatic Surgery at Legacy Good Samaritan Medical Center in Portland, Oregon, and as the Medical Director of Liver and Pancreas Surgery at Providence Cancer Center, also in Portland.
  • Dr. Wolf received his medical degree from Oregon Health & Science University in Portland, followed by an internship and two residencies in general surgery at UC Davis.

Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice

Retrieved on: 
Tuesday, October 17, 2023
Immunosuppression, Survival, Div, Stanford University School of Medicine, MD, Manuscript, PD-L1, Surgical oncology, UNO, 4T1, Administration, Immunotherapy, Associate, Science, PD-1, Pharmaceutical industry, Vaccine, M1, Surgery, Cell

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, announced today the publication of pre-clinical data demonstrating that its proprietary technology reduces immunosuppression and creates a favorable microenvironment that can contribute to immune potentiation.

Key Points: 
  • The data were published in an article entitled, “Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice,” in the peer-reviewed journal Cells.
  • The article is available on the Cells website.
  • “The combination of UNO and anti-mPD-1 resulted in a potent, synergistic immune response,” stated Dr. Hila Confino, Head of In Vivo Studies.
  • “I am excited for the presentation of our initial clinical data at SITC.”

Kanvas Biosciences Acquires Federation Bio Assets to Scale the Discovery, Development and Manufacturing of Microbiome-Based Therapeutics

Retrieved on: 
Wednesday, October 11, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Infectious Diseases, Health Technology, Partnership, DSM-IV codes, Lung cancer, FMT, Acquisition, LBP, Genetic distance, Google Maps, Dysbiosis, Biology, Piper LBP, Translational research, Intellectual property, Therapy, Surgical oncology, Recurrence, Cancer, MD Anderson Cancer Center, Federation, Melanoma, University, Immunotherapy, Inflammatory bowel disease, Monroe Dunaway Anderson, Lion Capital LLP, Patient, Pharmaceutical industry, Medical imaging, Nature

The deal also expands the company’s leadership and West Coast presence with the addition of Lee Swem , formerly Federation Bio’s Chief Science Officer, who joined Kanvas Biosciences as Chief Development Officer.

Key Points: 
  • The deal also expands the company’s leadership and West Coast presence with the addition of Lee Swem , formerly Federation Bio’s Chief Science Officer, who joined Kanvas Biosciences as Chief Development Officer.
  • “Kanvas Biosciences is leading the way in understanding exactly how the microbiome benefits human health.
  • With novel spatial biology and manufacturing platforms, Kanvas Biosciences is creating a first-in-category company capable of leveraging complex microbial therapies with hundreds of members simultaneously.
  • With early pre-clinical data showing promising results, Kanvas Biosciences and MD Anderson will soon begin drug manufacturing.

Clarix Imaging Secures $10 Million in New Funding from kineo finance to Transform Surgical Oncology

Retrieved on: 
Wednesday, October 4, 2023
Radiology, Biotechnology, Finance, Surgery, Oncology, Health, Medical Devices, Professional Services, Breast Cancer Awareness Month, Partnership, Surgeon, Senior, Intelligence, Imaging, Surgical oncology, Hospital, Traction, Patient, Breast cancer, Risk, Growth, Medical imaging

Clarix Imaging , a medical technology company revolutionizing surgical oncology, today announces $10 million in funding from kineo finance , a Swiss-headquartered investment firm.

Key Points: 
  • Clarix Imaging , a medical technology company revolutionizing surgical oncology, today announces $10 million in funding from kineo finance , a Swiss-headquartered investment firm.
  • With the risk of re-excisions of lumpectomies as high as 25% at some hospitals, Clarix Imaging’s volumetric specimen imaging system is a state-of-the-art, point-of-care 3D imaging platform that enables real-time assessment of surgical specimens in the operating room.
  • “Clarix Imaging has demonstrated remarkable traction by addressing a fundamental unmet need in lumpectomies, and we are extremely excited to welcome them to our portfolio of companies,” said Lee Hsieh, Senior Vice President of kineo finance.
  • “As we execute our ambitious growth priorities, we are thrilled to be guided by kineo finance’s deep expertise in the global medical technology industry.”
    Stay healthy.